Provider Resources WA

11/24/25 Health News: Statement Regarding Vaccines and Autism

On November 21 the Department of Health and the West Coast Health Alliance issued statements regarding vaccines and autism. In short, vaccines are thoroughly tested and remain one of the most important tools we have for preventing infectious diseases. They represent one of the greatest public health achievements in history, having saved millions of lives 11/24/25 Health News: Statement Regarding Vaccines and Autism

11/20/25 Provider Alert: Case of H5N5 Influenza Confirmed in Washington

Flock of chickens

Current Situation On November 13, 2025, a Washington resident who has been hospitalized with respiratory illness symptoms since early November tested positive for influenza A H5, a type of avian influenza. Subsequent sequencing confirmed the patient was infected with H5N5 influenza virus. To our knowledge, this is the first known human case of H5N5. The 11/20/25 Provider Alert: Case of H5N5 Influenza Confirmed in Washington

09/23/25 News Alert: DOH and Health Partners Emphasize the Need for Equitable Access and Evidence-Based Vaccine Policy

Statewide Standing Order for COVID-19 Vaccines To support Washingtonians in their efforts to protect themselves from COVID-19 infection using the best available science, DOH issued a statewide standing order for COVID-19 vaccines. This standing order under the direction of the State Health Officer, authorizes qualified health care professionals to vaccinate individuals aged 6 months and 09/23/25 News Alert: DOH and Health Partners Emphasize the Need for Equitable Access and Evidence-Based Vaccine Policy

09/15/25 Health Advisory: 2025–2026 respiratory-illness season vaccine recommendations

Gloved hand squeeze bicep while giving a shot.

Summary Influenza COVID-19 RSV Co-administration of COVID-19, flu, and RSV vaccines is safe. Vaccination is one of the best ways to prevent severe disease and hospitalization. COVID-19 vaccine recommendations and Washington State Department of Health (DOH) support evidence-based recommendations from trusted national medical specialty societies, including the American Academy of Pediatrics (AAP), the American Academy 09/15/25 Health Advisory: 2025–2026 respiratory-illness season vaccine recommendations

07/25/25 Health Advisory: Pfizer recall of Benzathine Penicillin G injectable suspension (Bicillin LA)

Yellow box outlined with black and black text that says "Recall"

Summary: Check your Bicillin LA and save remaining supply to treat pregnant people and infants with syphilis. Pfizer voluntarily recalled 12 lots of Benzathine Penicillin G Injectable Suspension (Bicillin LA) after particulates were found during a visual inspection. The recall comes amid high syphilis diagnoses across the U.S. Penicillin is the only recommended treatment for pregnant people 07/25/25 Health Advisory: Pfizer recall of Benzathine Penicillin G injectable suspension (Bicillin LA)

07/03/25 Health Advisory: Screening guidance for Candida auris in light of new local cases

Summary: Upgrade screening and preparation for Candida auris. Two facilities in Seattle have known transmission of Candida auris (C. auris). We have limited information about how much transmission is occurring in Washington. We recommend that you: Early screening is critical for rapid identification so you can quickly implement infection control measures and prevent spread at your facility.  Background As of 07/03/25 Health Advisory: Screening guidance for Candida auris in light of new local cases

10/23/24 Health Advisory: Presumed positive human cases of avian influenza in Washington.

Washington State Department of Health is investigating presumed positive human cases of avian influenza in Washington. Healthcare providers should consider avian influenza in patients who present with acute respiratory illness, isolated conjunctivitis, or influenza-like illness (ILI). Assess patients for exposure to animals––especially poultry, cattle, and wildlife, or to people suspected or known to be infected.  Current 10/23/24 Health Advisory: Presumed positive human cases of avian influenza in Washington.

10/17/24 Health Advisory: Disruptions in Availability of Peritoneal Dialysis and Intravenous Solutions from Baxter International Facility in North Carolina

IV bags hanging from an IV pole.

BackgroundOver several days in late September 2024, Hurricane Helene caused extensive damage to the southeastern United States. The storm affected the Baxter International’s North Cove facility in North Carolina, the largest manufacturer of peritoneal dialysis and intravenous solutions in the United States, halting production. Additional supply disruption may occur in the aftermath of Hurricane Milton. Recommendations for Healthcare 10/17/24 Health Advisory: Disruptions in Availability of Peritoneal Dialysis and Intravenous Solutions from Baxter International Facility in North Carolina

09/23/24 Health Advisory: 2024–2025 Respiratory Illness Season Vaccine Recommendations

Gloved hand squeeze bicep while giving a shot.

Summary COVID-19 vaccine recommendations For most people, the minimum interval between their last 2023–2024 COVID-19 vaccine dose and their 2024–2025 COVID-19 vaccine dose is 8 weeks. There are exceptions for people completing a multidose initial vaccination series, including: Learn more in CDC’s detailed vaccination schedules for people who are not moderately or severely immunocompromised and people who are 09/23/24 Health Advisory: 2024–2025 Respiratory Illness Season Vaccine Recommendations

08/01/24 Provider Alert: Ongoing transmission of Candida auris identified in Washington.

Background C. auris is an emerging, often multi-drug resistant yeast, that was first identified in the US in 2009. The first locally acquired case of C. auris in Washington was reported in 2023, and the first outbreak was  reported in January 2024. It can cause difficult to control outbreaks in high acuity facilities, especially among 08/01/24 Provider Alert: Ongoing transmission of Candida auris identified in Washington.